Effects of nonoral estradiol–micronized progesterone or low-dose oral estradiol–drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause-Reference-Cited by-同舟云学术

Effects of nonoral estradiol–micronized progesterone or low-dose oral estradiol–drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause

Published:2009-08 Issue:2 Volume:92 Page:605-612
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Casanova Gislaine,Radavelli Simone,Lhullier Francisco,Spritzer Poli Mara

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference67 articles.

1. Estrogen replacement therapy, atherosclerosis, and vascular function;Mikkola;Cardiovasc Res,2002

2. Coronary heart disease: reducing the risk. A worldwide view;Assmann;Circulation,1999

3. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression;Clarkson;Menopause,2007

4. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-Up Study;Bush;Circulation,1987

5. Postmenopausal hormone therapy and mortality;Grodstein;N Engl J Med,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women;Climacteric;2022-11-18

2. The Effects of Menopause Hormone Therapy on Lipid Profile in Postmenopausal Women: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2022-04-12

3. Impact of micronized progesterone on body weight, body mass index, and glucose metabolism: a systematic review;Climacteric;2018-11-27

4. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis;Thrombosis Research;2018-08

5. Safety and benefit considerations for menopausal hormone therapy;Expert Opinion on Drug Safety;2017-06-30